Lee Frank D. 4
4 · Bolt Biotherapeutics, Inc. · Filed Jun 14, 2024
Insider Transaction Report
Form 4
Lee Frank D.
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-12+22,000→ 22,000 totalExercise: $0.77Exp: 2034-06-11→ Common Stock (22,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest on the earlier of June 12, 2025 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer.